|
In this issue:
|
|
|
|
|
Prostate cancer screening in Europe is a 'significant milestone'
New report from European Cancer Organisation charts progress and disparities
|
|
|
|
|
One in four cancers in men are prostate cancer
Incidence figures across Europe reflect screening practices
|
|
|
|
|
Low risk prostate cancer is still cancer
New report puts the patient perspective on the issue
|
|
|
Prostate research and treatments
Hereditary gene increases risk of prostate cancer
The USA Vanderbilt University Medical Center has published a study on men with a family history of prostate cancer and discovered an inherited form of prostate cancer. They say the inherited mutated gene WNT9B increases risk of adult prostate cancer.
Read the article here.
|
|
|
Collection of articles from nuclear medicine conference
The European Association of Nuclear Medicine (EANM) has published the Hamburg Collection, a set of eight articles capturing essential themes presented at their last EANM Congress. Europa Uomo’s Vice Chairman Erik Briers was one of the speakers.
One article explains radioligand therapy, a type of treatment given to enhance quality of life and survival especially in cases of castration-resistant prostate cancer that has spread to the bone.
One novel radioligand therapy, 68GA-PSMA-11/CT, specifically binds to PSMA (PSMA-ligands).
Articles also cover the need for PSMA-PET for radiation oncology and the way that theranostics (Lutetium) is bringing prostate cancer patients new hope.
|
|
|
New article on organised screening in Europe
Jens J. Madsen, a member of Danish prostate cancer patient organisation Propa, has written an article entitled “Unorganized and organized screening for prostate cancer in Europe today”. You can read the article here.
|
|
|
Europa Uomo News
Europa Uomo's webinar on the ProCAncer-I project
At our next Europa Uomo webinar, on Wednesday 12th March at 6-7pm CET, Kai Vilanova will speak about “The ProCAncer-I project: artificial intelligence in the diagnosis of prostate cancer”. You can view the programme here.
Please register in advance for this meeting: https://us02web.zoom.us/meeting/register/Ec-3i5dYSVOuKyr3zNgcpw After registering, you will receive a confirmation email containing information about joining the meeting.
|
|
|
Use the Europa Uomo chatbot
You can find the Europa Uomo/EAU chatbot, trained through artificial intelligence in the EAU’s prostate cancer guidelines, on every page of the Europa Uomo website (europa-uomo.org). Just click on the blue speech bubble logo in the lower right corner. See images below.
 
The chatbot is available in 99 languages. It always starts in English, but if you ask questions in your own language then the chatbot will respond in that language.
Please try it yourself and publicise among local patients.
|
|
|
|
|
|
FREE SUBSCRIPTION TO EUROPA UOMO MONTHLY UPDATE
All previous issues are available on website: www.europa-uomo.org/newsletters/
|
|
